Transform Drug Policy Foundation look beyond the use of psychedelics solely for therapeutic use, examining how to shape policy and regulation for psychedelics outside the medical sphere.
To celebrate the launch of their new publication, Transform are hosting a webinar to discuss the key challenges in regulating psychedelics, as well as proposed regulatory models that seek to fill the gap between medical and therapeutic uses.
While the bill still requires approval from the governor, the Senate's approval marks a significant step toward promoting safe and regulated access to psychedelics in California.
While the legalisation of psychedelics is a positive step toward global drug policy reform, it must not be at the expense of Indigenous communities, who have used psychoactive plants for emotional, physical, and spiritual healing for centuries.
Explore the transformative potential of psychedelics on the human mind in this free online 8-module course from the University of California, Berkeley.
The EMCDDA shed light on emerging trends, challenges, and policy implications surrounding drug use in Europe up until the end of 2022, revealing high availability of substances and a greater need for harm reduction services.
Brandt provides insight on how the pharmacy profession can play a role in legal reform, regulatory policy creation, and pharmacy operations to broaden access to psychedelics while mitigating harm, using Canada as a case study.
Celidwen et al. provide a framework to consider more respectful relationships between Western institutions and Indigenous psychedelic medicines, with a view to resist extraction and commercialisation.
